Article

Biosimilar Litigation Review: Anticompetitive Conduct Cases & Post-Grant Patent Challenges

Authors

The final article of a four-part series on 2019 legal developments related to the biosimilar sector is now available. Written by Fish principal Jenny Shmuel and associates Philip Chen and Felix Eyzaguirre, this article focuses on 2019 biosimilar litigation related to anticompetitive conduct and post-grant patent challenges at the Patent Trial and Appeal Board (PTAB), and looks to what biosimilar developers can anticipate throughout 2020.

Read the "Biosimilar Litigation Review: Anticompetitive Conduct Cases & Post-Grant Patent Challenges” full article.